Entrepreneurs Danny Cabrera and Ricky Solorzano have made the Forbes “30 under 30” list for 2016. The founders of BioBots, a MicroVentures portfolio company, appear in the manufacturing category of this esteemed list.

Based in Philadelphia, BioBots manufactures bioprinters, which are essentially 3D printers capable of printing living tissue. Instead of using plastic as a raw material, the first-generation BioBots printer uses cells and “biocompatible” material to print dozens of different cell types. Medical researchers are using the technology to develop human organ models, facilitate clinical drug trials, and even experiment with printing bone.

Bioprinters are uncommon enough, but even in this niche market BioBots distinguishes itself. For one thing, the printer is desktop-sized, measuring one cubic foot. It also costs a fraction of “traditional” bioprinters, and it doesn’t require a team of people to operate it. These are just a handful of the reasons BioBots won the “Most Innovative” award at SXSW Accelerator here in Austin last year.

MicroVentures invested in BioBots as part of their $1.25 million seed round last year, alongside Dreamit Ventures, 500 Startups, and Ben Franklin Technology Partners. Stay tuned to the MicroVentures blog for more news on our portfolio companies and for topics of interest to investors and entrepreneurs alike.